Sepsis on the increase in U.S., according to Emory University and CDC study

May 21, 2002

The incidence of sepsis -- a severe, whole-body immune response to infection -- is increasing by an average of 16% a year in the U.S., according to research by investigators at Emory University School of Medicine and the Centers for Disease Control and Prevention (CDC). During the 20-year period from 1979 to 1999, the incidence of sepsis increased by more than 329%, from 78 to 259 cases per 100,000 people. Sepsis is a major public health problem, consuming more than $15 billion in healthcare costs annually in the U.S.

Emory pulmonologist and intensivist Greg Martin, M.D., in collaboration with Marc Moss, M.D., of Emory and David Mannino, M.D., of the CDC presented results of their analysis of data from the U.S. National Hospital Discharge Survey at the annual meeting of the American Thoracic Society in Atlanta on Tuesday. The study is the most comprehensive survey of sepsis epidemiology to date because it includes statistics from the entire country over a long period of time.

The scientists used selected groupings of clinical disease classification codes to identify patients with sepsis. The incidence of sepsis increased in both children and adults during the 20-year period. Males, African-Americans, and other non-Caucasians had the highest rates of hospitalization due to sepsis, although the incidence in females and Caucasians increased more rapidly. The study also indicated an increase in gram-positive infections, which by 1999 represented the majority of cases of sepsis (56%), while gram-negative infections, anaerobic, fungal and viral infections were less common. Although relatively uncommon, the greatest increase was in sepsis cases with fungal infections as their source.

Although sepsis begins with an identifiable infection, when patients become septic their immune systems are intensely activated, setting off a cascade of events that may result in uncontrolled inflammation throughout the body. Sepsis also activates the coagulation system by promoting thrombosis and inhibiting fibrinolysis, which is how the body breaks up clots. These changes may contribute to multiple organ failure, which is a major cause of mortality from sepsis.

Following years of research on sepsis, scientists last year introduced the first effective specific therapy -- the drug Xigris, which is activated protein C, a recombinant form of a natural anticoagulant. Xigris is effective because it is an anti-coagulant that also reduces inflammation. Before Xigris, the mainstay of therapy was general, broad-spectrum antibiotics and supportive care.

Physicians must be able to recognize sepsis quickly in order to treat it. "Studies show that if you wait even four to eight hours to begin antibiotic therapy, the mortality from sepsis worsens considerably," notes Dr. Martin. "And antibiotics must be appropriate. Patients with severe sepsis are in shock, with organ failure, respiratory failure, and renal failure. Although the mortality with severe sepsis is approximately 30% to 40%, Xigris reduces that to approximately 25%.

Although there has been no scientific study to identify the reasons for the increase in sepsis, Dr. Martin offers several explanations. "Physicians are identifying more cases of sepsis because they are aware of how sepsis differs from other infections," he says. "And sepsis is actually occurring more frequently due to the overuse of antibiotics and the development of resistant organisms. This is apparent in the shift towards gram-positive organisms as the cause of sepsis and the increase in fungal causes. Improvements in care among individuals with altered immunities also could be leading to an increase in sepsis. For example, antiretroviral therapy has led to increased longevity for HIV patients, and we have more patients receiving organ transplants, bone marrow transplants, and high-dose chemotherapy who are vulnerable to infection. An increase in medical and surgical procedures that breach body barriers also predisposes more patients to sepsis."

According to earlier research, 80% of patients with sepsis develop it outside the hospital, while only 20% develop it while in a hospital or nursing home. Although the incidence of sepsis is increasing, with more than 700,000 cases per year, the mortality appears to be decreasing, from 29% of cases in 1979 to 17.4% in 1999. Because of the increased incidence, however, more people continue to die each year.

Physicians have become much more adept at diagnosing sepsis, according to Dr. Martin, partly because of a consensus definition that includes criteria such as changes in temperature, heart rate, respiratory function, and white blood cell count. Sepsis is defined as being an initial infection plus at least two of these four additional criteria.

"This makes it much easier for physicians to walk to the bedside and identify patients with sepsis, including those at highest risk," Dr. Martin says. "If a patient has sepsis with organ failure, physicians need to be very aggressive with treatment.

"Not only do we need to treat sepsis promptly and aggressively, we also need to educate the entire physician community about how to recognize sepsis early or prevent sepsis in high-risk patients, We also need to examine how antibiotics, medical procedures, and an increase in immune-compromised patients and elderly patients represent increased risk for sepsis. A new understanding of sepsis could have a major impact on patients and healthcare resources," Dr. Martin emphasizes.
-end-
The study was funded by Emory University and the National Institutes of Health.

Emory University Health Sciences Center

Related Antibiotics Articles from Brightsurf:

Insights in the search for new antibiotics
A collaborative research team from the University of Oklahoma, the Memorial Sloan Kettering Cancer Center and Merck & Co. published an opinion article in the journal, Nature Chemical Biology, that addresses the gap in the discovery of new antibiotics.

New tricks for old antibiotics
The study published in the journal Immunity reveals that tetracyclines (broad spectre antibiotics), by partially inhibiting cell mitochondria activity, induce a compensatory response on the organism that decreases tissue damage caused during infection.

Benefits, risks seen with antibiotics-first for appendicitis
Antibiotics are a good choice for some patients with appendicitis but not all, according to study results published today in the New England Journal of Medicine.

How antibiotics interact
Understanding bottleneck effects in the translation of bacterial proteins can lead to a more effective combination of antibiotics / study in 'Nature Communications'

Are antivitamins the new antibiotics?
Antibiotics are among the most important discoveries of modern medicine and have saved millions of lives since the discovery of penicillin almost 100 years ago.

Hygiene reduces the need for antibiotics by up to 30%
A new paper published in the American Journal of Infection Control (AJIC), finds improved everyday hygiene practices, such as hand-washing, reduces the risk of common infections by up to 50%, reducing the need for antibiotics, by up to 30%.

Antibiotics: City dwellers and children take the most
City dwellers take more antibiotics than people in rural areas; children and the elderly use them more often than middle-aged people; the use of antibiotics decreases as education increases, but only in rich countries: These are three of the more striking trends identified by researchers of the NRW Forschungskolleg ''One Health and Urban Transformation'' at the University of Bonn.

Metals could be the link to new antibiotics
Compounds containing metals could hold the key to the next generation of antibiotics to combat the growing threat of global antibiotic resistance.

Antibiotics from the sea
The team led by Prof. Christian Jogler of Friedrich Schiller University, Jena, has succeeded in cultivating several dozen marine bacteria in the laboratory -- bacteria that had previously been paid little attention.

Antibiotics not necessary for most toothaches, according to new ADA guideline
The American Dental Association (ADA) announced today a new guideline indicating that in most cases, antibiotics are not recommended for toothaches.

Read More: Antibiotics News and Antibiotics Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.